Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Risk-benefit analysis of intrathecal morphine for proximal femoral fracture surgery
2024-513996-42-00Phase 3Completed
- Sponsor
- University Hospital Ostrava
- Start
- Oct 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of morphine in hip fracture (2 arms), sponsored by University Hospital Ostrava. Primary endpoints: Pain at rest using VAS10, Pain during positioning using VAS10 and 3 more. Started Oct 2024; status: completed.
02
Drugs
morphine
03
Conditions
hip fracture
Beyond the preview
Go deeper on 2024-513996-42-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-513996-42-00.